We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Studies
Pec5.7
Pectin Research
Mostly mechanism / observational
8 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Pectin studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 1985–2022 with a typical study size of 30 participants.
Based on 8 studies · 1 meta-analysis · 4 RCTs · 164 total participants
Confidence
Moderate confidence
By outcome
Cholesterol & lipidsModest reduction in total and LDL cholesterol · 3-4 weeks
Mostly mechanism / observational4 studies
Heart & blood pressureModest reduction in total and LDL cholesterol · 3-4 weeks
Too few graded studies1 study
Weight managementIncreased satiety and delayed gastric emptying; modest effect on intake · 4-8 weeks
Too few graded studies1 study
Micronutrient & trace-element status
Too few graded studies1 study
By the numbers
Pulled from 8 studies with measurable effects
People studied
164
typical study: 30 people
Strongest designs
5
1 pooled, 4 randomised
Populations Studied
Adults2
Healthy adults2
Animal models1
Overweight and obese adults1
Steady research
1 study in the last 5 years · Latest meta-analysis: 1999
198520032022
1Total and LDL cholesterol reductionMeta-Analysis1999
In plain English: Various soluble fibers reduce total and LDL cholesterol by similar amounts. The effect is small within the practical range of intake.
Brown L et al. · The American journal of clinical nutrition (1999)
Meta-analysis of 67 controlled trials directly tested pectin, oat bran, guar gum, and psyllium against blood lipids.
Soluble fiber at 2-10 g/d was associated with small but significant decreases in total cholesterol (-0.045 mmol/L per gram; 95% CI: -0.054, -0.035) and LDL cholesterol (-0.057 mmol/L per gram; 95% CI: -0.070, -0.044).
The lipid-lowering effect of pectin was not significantly different from that of oat or psyllium.
2Cholesterol and cardiometabolic markersSystematic Review2022
In plain English: Our investigation revealed that apples could improve blood cholesterol levels.
Kim SJ et al. · Frontiers in nutrition (2022)
Eighteen RCTs of whole apple, apple extract, and apple juice — key dietary sources of pectin — were pooled across nine cardiometabolic outcomes.
Total cholesterol (-2.69 mg/dL) and LDL (-2.80 mg/dL) showed a non-significant downward trend overall, but the reduction became significant versus placebo controls and in subjects with high baseline cholesterol.
Apple and apple-derived products modestly reduced HDL cholesterol (-1.04 mg/dL; 95% CI: -1.79, -0.29).
4Appetite and energy intakeCrossovern=29 · very small study2014
In plain English: Results suggest that different physicochemical properties of pectin, including methods of supplementation, impact appetite and energy intake differently.
Wanders AJ et al. · Physiology & behavior (2014)
Randomized crossover in 29 subjects comparing no pectin, bulking pectin, viscous pectin, and gelled pectin (10 g) in dairy-based test products.
Gelled pectin reduced appetite more than bulking, viscous, or no pectin (p < 0.0001) and delayed gastric emptying (82 ± 18 vs. 70 ± 19 min; p = 0.015).
Despite reduced appetite, there was no significant difference in subsequent energy intake (p = 0.32).
In plain English: This study suggests that soluble fibres are not all created equal.
Salleh SN et al. · Foods (2019)
Meta-analysis of RCTs pooling the effect of individual soluble fibres on post-meal energy intake.
Pectin had the smallest pooled effect on energy intake (effect size -0.26) among the fibres examined, behind guar gum (-0.90), β-glucan (-0.44), alginate (-0.42), and polydextrose (-0.36).
Guar gum, alginate, and high-dose polydextrose significantly reduced energy intake, whereas pectin's effect was weaker.
6Energy intake and glycemic parametersRCTn=96 · small study2014
In plain English: There was a directional benefit in ad libitum energy intake for both OFS + P doses compared to control, but the reductions were not significant.
Savastano DM et al. · Nutrition journal (2014)
Randomized, double-blind, placebo-controlled trial in 96 overweight/obese adults testing oligofructose plus pectin (OFS + P) at 30 g/d and 15 g/d against a maltodextrin control for 3 weeks.
Energy intake fell more with pectin-containing fiber (-58.3 kcal high dose, -74.2 kcal low dose) than control (-9.0 kcal), but the difference was not statistically significant (p = 0.54).
No significant differences in glycemic parameters were seen across groups.
7Gastric emptying and satietyRCTn=9 · very small study1988
In plain English: As pectin induces satiety and delays gastric emptying in obese patients, it may be a useful adjuvant in the treatment of disorders of overeating.
Di Lorenzo C et al. · Gastroenterology (1988)
Randomized crossover in 9 obese adults comparing 15 g pectin added to a meal versus 15 g methylcellulose control.
Pectin significantly delayed gastric emptying half-time (116 ± 23 min vs. 71 ± 17 min; p < 0.001).
Pectin significantly increased the sensation of satiety (98 ± 7 vs. 74 ± 17; p < 0.001).
In plain English: Neither pectin, cellulose, nor lignin significantly altered serum total cholesterol, triglycerides, high-density lipoprotein cholesterol, or the ratio of high-density lipoprotein to total cholesterol in healthy normolipidemic subjects.
Hillman LC et al. · The American journal of clinical nutrition (1985)
Eight-week randomized crossover studies in three groups of 10 healthy volunteers testing pectin (12 g/d), cellulose (15 g/d), and lignin (12 g/d).
None of the three fibers significantly altered serum total cholesterol, triglycerides, or HDL cholesterol in these normolipidemic subjects.
The null result illustrates that pectin's lipid effect is smaller and less reliable in people who already have normal cholesterol.